Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT nanoparticles.

A novel method for the fabrication of polymeric particles on the order of tens of nanometers to several microns is described. This imprint lithographic technique called PRINT (Particle Replication In Non-wetting Templates), takes advantage of the unique properties of elastomeric molds comprised of a low surface energy perfluoropolyether network, allowing the production of monodisperse, shape-specific nanoparticles from an extensive array of organic precursors. This engineered nature of particle production has a number of advantages over the construction of traditional nanoparticles such as liposomes, dendrimers, and colloidal precipitates. The gentle "top down" approach of PRINT enables the simultaneous and independent control over particle size and shape, composition, and surface functionality, and permits the loading of delicate cargos such as small organic therapeutics and biological macromolecules. Thus, this single tool serves as a comprehensive platform for the rational design and investigation of new nanocarriers in medicine, having applications ranging from therapeutics to advanced diagnostics. Preliminary in vitro and in vivo studies were conducted, demonstrating the future utility of PRINT particles as delivery vectors in nanomedicine. Monodisperse 200 nm poly(ethylene glycol)-based (PEG) particles were fabricated using PRINT methodology and characterized via scanning electron microscopy and dynamic light scattering. Incubation with HeLa cells showed very little cytotoxicity, even at high concentrations. The biodistribution and pharmacokinetics of [(125)I]-labeled particles were studied in healthy mice following bolus tail vein administration. The particles were distributed mainly to the liver and the spleen with an apparent distribution t(1/2) of approximately 17 min followed by slow redistribution with a t(1/2) of 3.3 h. The volume of distribution for the central and peripheral compartments was found to be approximately 3 mL and 5 mL, respectively.

[1]  D. Crommelin,et al.  The effect of aging on the physical stability of liposome dispersions. , 1992, Chemistry and physics of lipids.

[2]  Yale N. Patt,et al.  One Billion Transistors, One Uniprocessor, One Chip , 1997, Computer.

[3]  J H Senior,et al.  Fate and behavior of liposomes in vivo: a review of controlling factors. , 1987, Critical reviews in therapeutic drug carrier systems.

[4]  María J Vicent,et al.  Polymer conjugates: nanosized medicines for treating cancer. , 2006, Trends in biotechnology.

[5]  R. Samulski,et al.  Polymeric nanogels produced via inverse microemulsion polymerization as potential gene and antisense delivery agents. , 2002, Journal of the American Chemical Society.

[6]  M. Hashida,et al.  Macromolecular Carrier Systems for Targeted Drug Delivery: Pharmacokinetic Considerations on Biodistribution , 1996, Pharmaceutical Research.

[7]  Francis C Szoka,et al.  Designing dendrimers for biological applications , 2005, Nature Biotechnology.

[8]  Nicholas A Peppas,et al.  Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.

[9]  J. G. Cory,et al.  5-(3-carboxymethoxyphenyl)-2-(4,5-dimethylthiazolyl)-3-(4-sulfophenyl)tetrazolium, inner salt (MTS) and related analogs of 3-(4,5-dimethylthiazolyl)-2,5-diphenyltetrazolium bromide (MTT) reducing to purple water-soluble formazans As cell-viability indicators , 1991 .

[10]  T. Allen,et al.  Pharmacokinetics of stealth versus conventional liposomes: effect of dose. , 1991, Biochimica et biophysica acta.

[11]  Ginger M. Denison,et al.  High-resolution soft lithography: enabling materials for nanotechnologies. , 2004, Angewandte Chemie.

[12]  A. C. Hunter,et al.  Nanomedicine: current status and future prospects , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  M. Woodle,et al.  Controlling liposome blood clearance by surface-grafted polymers. , 1998, Advanced drug delivery reviews.

[14]  V. Torchilin Polymer-coated long-circulating microparticulate pharmaceuticals. , 1998, Journal of microencapsulation.

[15]  Kazunori Kataoka,et al.  Block copolymer micelles as long-circulating drug vehicles , 1995 .

[16]  Joseph M DeSimone,et al.  Direct fabrication and harvesting of monodisperse, shape-specific nanobiomaterials. , 2005, Journal of the American Chemical Society.

[17]  Stephanie E. A. Gratton,et al.  Imparting size, shape, and composition control of materials for nanomedicine. , 2006, Chemical Society reviews.

[18]  V. Torchilin,et al.  Targeted polymeric micelles for delivery of poorly soluble drugs , 2004, Cellular and Molecular Life Sciences CMLS.

[19]  T. Baker,et al.  Adding the Third Dimension to Virus Life Cycles: Three-Dimensional Reconstruction of Icosahedral Viruses from Cryo-Electron Micrographs , 2000, Microbiology and Molecular Biology Reviews.

[20]  E. Henze,et al.  Iodine-123 labelling of atrial natriuretic peptide and its analogues: initial results , 1993, European Journal of Nuclear Medicine.

[21]  F. Szoka,et al.  Acid-triggered transformation of diortho ester phosphocholine liposome. , 2006, Journal of the American Chemical Society.

[22]  P. Cullis,et al.  β2-Glycoprotein I Is a Major Protein Associated with Very Rapidly Cleared Liposomes in Vivo, Suggesting a Significant Role in the Immune Clearance of "Non-self" Particles (*) , 1995, The Journal of Biological Chemistry.

[23]  R. Duncan The dawning era of polymer therapeutics , 2003, Nature Reviews Drug Discovery.

[24]  Theresa M. Allen,et al.  Pharmacokinetics of long-circulating liposomes , 1995 .

[25]  D. Papahadjopoulos,et al.  Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. , 1999, Pharmacological reviews.

[26]  Papisov Theoretical considerations of RES-avoiding liposomes: Molecular mechanics and chemistry of liposome interactions. , 1998, Advanced drug delivery reviews.

[27]  T. Okano,et al.  Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[28]  G Gregoriadis,et al.  Engineering liposomes for drug delivery: progress and problems. , 1995, Trends in biotechnology.

[29]  Yechezkel Barenholz,et al.  Liposome application: problems and prospects , 2001 .

[30]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.